Association between 5-lipoxygenase expression and plaque instability in humans. - Wikidata - wikimedia - TriplyDB

Association between 5-lipoxygenase expression and plaque instability in humans.

Association between 5-lipoxygenase expression and plaque instability in humans.

http://www.wikidata.org/entity/Q46525384

about

Emerging Comorbidities in Adult Asthma: Risks, Clinical Associations, and Mechanisms Cysteinyl Leukotrienes and Their Receptors: Emerging Therapeutic Targets in Central Nervous System Disorders 5-Lipoxygenase Gene Variants Are Not Associated With Atherosclerosis or Incident Coronary Heart Disease in the Multi-Ethnic Study of Atherosclerosis Cohort Oxidative risk for atherothrombotic cardiovascular disease.Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease.Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins.High prevalence of human cytomegalovirus in carotid atherosclerotic plaques obtained from Russian patients undergoing carotid endarterectomy Genotyping the GGGCGG tandem repeat promoter polymorphism in the 5-lipoxygenase enzyme gene (ALOX5) by pyrosequencing assay.Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability.Complex inheritance of the 5-lipoxygenase locus influencing atherosclerosis in mice Reactive oxygen species in cardiovascular disease.Leukotriene B4 receptor-1 mediates intermittent hypoxia-induced atherogenesis.EETs Attenuate Ox-LDL-Induced LTB4 Production and Activity by Inhibiting p38 MAPK Phosphorylation and 5-LO/BLT1 Receptor Expression in Rat Pulmonary Arterial Endothelial Cells.Common Polymorphisms in the 5-Lipoxygenase Pathway and Risk of Incident Myocardial Infarction: A Danish Case-Cohort Study.Overview of the pharmacogenetics of asthma treatment.Adipose tissue arachidonic acid content is associated with the expression of 5-lipoxygenase in atherosclerotic plaques.Leukotriene receptors in atherosclerosis.The potential link between atherosclerosis and the 5-lipoxygenase pathway: investigational agents with new implications for the cardiovascular field.Leukotriene signaling in atherosclerosis and ischemia Genetic effects in the leukotriene biosynthesis pathway and association with atherosclerosis.Leukotriene B4 levels in human atherosclerotic plaques and abdominal aortic aneurysms.Anti-inflammatory therapeutics for the treatment of atherosclerosis.5-Lipoxygenase inhibitors: a review of recent developments and patents.Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.Emerging anti-inflammatory drugs for atherosclerosis.Arterial inflammation in bronchial asthma.Anti-HMG-CoA Reductase, Antioxidant, and Anti-Inflammatory Activities of Amaranthus viridis Leaf Extract as a Potential Treatment for Hypercholesterolemia.Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular Diseases.Expression Profiling of Genes Related to Endothelial Cells Biology in Patients with Type 2 Diabetes and Patients with Prediabetes.Influence of aspirin on SR-BI expression in human carotid plaques.Association of ALOX5, LTA4H and LTC4S gene polymorphisms with ischemic stroke risk in a cohort of Chinese in east China.Lipoxygenase and prostaglandin G/H synthase cascades in cardiovascular disease.5-lipoxygenase inhibitor zileuton attenuates ischemic brain damage: involvement of matrix metalloproteinase 9.Leptin induces macrophage lipid body formation by a phosphatidylinositol 3-kinase- and mammalian target of rapamycin-dependent mechanism.Initial Clinical Experience with AZD5718, a Novel Once Daily Oral 5-Lipoxygenase Activating Protein Inhibitor.Impact of inflammation, gene variants, and cigarette smoking on coronary artery disease risk Research Progress on the Relationship between Atherosclerosis and Inflammation

P2860

Q26747066-09E5035F-E276-49EA-940A-EB61E03FC95B Q28278005-F84AB6EF-B9D8-4696-B51F-949CE4333BA1 Q30277078-66C0743C-B8B6-4DD1-9A84-F09E74965D63 Q33554184-71BE485F-7DE8-47EE-B5B5-A9897CB74942 Q33622665-E8AB0226-D5B9-442E-9B0C-AD98583D5151 Q34113615-15B47DC4-2044-4EDB-A6A6-F4A63254B41B Q34253980-4D88886A-3B4B-4006-B539-4E717A48FDD9 Q34385384-7975EE70-E2B7-4E79-8DCA-3FB92E1C3C30 Q34601356-0A71A346-7C89-4D3C-A6ED-DA9A774A877F Q34895911-30AC7620-2804-4FAF-992E-B255E7A2866C Q35165194-87CC15E4-FE2A-4832-A71A-0BB5D389E192 Q35212608-2BFBC07C-674A-41D8-B3EF-873F33E3C73A Q35649907-0DB10E75-04CD-4E9D-BEAA-264F0147FB60 Q36205625-2DCE3A99-C8EA-472C-9527-7CE1C6531AAA Q36433595-D6AB162E-7A38-4064-8B53-92C9612FFDE3 Q36578662-0C404EEE-A671-4564-ACED-4B2040065354 Q36652544-FCEFE3CC-53F7-415F-A14D-7222B8821804 Q37016080-1A862C63-0AC8-4CCA-BA22-4084717AD987 Q37145833-2E533339-695A-4826-93A6-B224EDFA27AC Q37380468-BAA27C99-F3A0-4457-B894-7E2488ACF7E1 Q37520764-920F936D-0BFD-4487-9DF2-901C2BD85F2C Q37626768-E7887614-3D2F-4A4C-8D03-DA1E037BBEA0 Q37697795-3AB7D392-D199-4FCD-96C9-24C24A05AF28 Q37995534-E72C498D-001A-4E4A-A85B-99AD901AC38B Q38106998-88B03972-F94A-4C33-8550-5EFE328381E4 Q38454054-6CC2874E-5DFD-4748-B22C-C50FC51993E4 Q39372300-2F14B54E-B427-44C0-BBC3-C8B16D852C1A Q41432422-8186D377-7681-4472-90B5-B02AD1401DA9 Q41984090-151371AA-4DCF-47F0-9C8E-83485A2D6CFA Q42098692-5E28EEEB-A52D-4247-8187-49D1AE82E551 Q42785053-63114D12-875D-49C8-8B67-2C4713E25FEC Q43061580-E3481B10-AE6E-40C8-BA35-41B4296C716E Q46077175-A7157CD2-810C-46D4-B3C2-676C43A6D842 Q46881358-A9D97E06-958B-432C-A8D3-1A7D086F9375 Q52667224-E3032E4B-1664-4FD2-A4FE-26C02055A796 Q54964580-ED313F46-A508-40D2-919F-BEB0C6087E0F Q58710440-D9F048DF-5B1F-4A47-9794-DEFA6437A01C

P2860

Association between 5-lipoxygenase expression and plaque instability in humans.

http://www.wikidata.org/entity/Q46525384

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Association between 5-lipoxygenase expression and plaque instability in humans.

@en

Association between 5-lipoxygenase expression and plaque instability in humans.

@nl

type

label

Association between 5-lipoxygenase expression and plaque instability in humans.

@en

Association between 5-lipoxygenase expression and plaque instability in humans.

@nl

prefLabel

Association between 5-lipoxygenase expression and plaque instability in humans.

@en

Association between 5-lipoxygenase expression and plaque instability in humans.

@nl

P1433

Q46525384-107D77C8-A8E1-44F0-A9A1-A0D2E35E517D

P1476

Q46525384-4F595C69-AA55-4099-A9F7-1D6EBB4AA996

P2093

Q46525384-74309708-D917-410A-AD21-18FAD29778EB

Q46525384-76A28453-07C1-4CAA-B949-2DB2DAC375E9

Q46525384-80C71D0F-C15A-4E40-A84F-BF2A5FD9B095

Q46525384-97B2AC68-256C-4ACB-BC37-C867C278D374

Q46525384-A577FF57-2B8E-4E19-9DC3-D4111BC473BC

Q46525384-B0AE01DA-9B48-4BEE-83C8-B672EA4E6540

Q46525384-DDEE38E3-1D73-449F-AD13-3C419BC2BB34

Q46525384-E2CDCFB6-F2EE-40E4-A914-A8C33732492A

Q46525384-ED1AD064-D65E-4F31-A292-47DB76814AA0

Q46525384-FA9CB4B0-875E-4BB4-91CE-455C8BDA859B

P304

Q46525384-B714CF17-70BC-4E29-A2EA-BF08DDF38890

P31

Q46525384-6545F42A-FFD4-42C8-B2C6-71EDADE38CA5

P356

Q46525384-38250D80-DBB0-4673-BD30-E9970BDAEBD1

P407

Q46525384-2BDCB67C-1937-4E39-B1A2-B639E9253DF0

P433

Q46525384-3BBCFCF2-4953-4AA0-B3A4-32E5F7704161

P478

Q46525384-74021BB3-E820-4542-9906-9A4DB5431E6D

P50

Q46525384-73CF9B2F-47E9-4D53-92E3-22B3CF42CAB1

P577

Q46525384-1B13A0CE-3845-45FC-9314-35DDEBB0E531

P698

Q46525384-8A43D542-5F30-4B1C-9EAC-8668FFE7503F

P356

01.ATV.0000172632.96987.2D

P1433

Arteriosclerosis, Thrombosis, and Vascular Biology

P1476

Association between 5-lipoxygenase expression and plaque instability in humans.

@en

P2093

Andrea Mezzetti

http://www.w3.org/2001/XMLSchema#string

Annalisa Iezzi

http://www.w3.org/2001/XMLSchema#string

Chiara Cuccurullo

http://www.w3.org/2001/XMLSchema#string

Diana M Stafforini

http://www.w3.org/2001/XMLSchema#string

Francesco Spigonardo

http://www.w3.org/2001/XMLSchema#string

Franco Cuccurullo

http://www.w3.org/2001/XMLSchema#string

Marco Bucci

http://www.w3.org/2001/XMLSchema#string

Maria Luigia Fazia

http://www.w3.org/2001/XMLSchema#string

Sante Ucchino

http://www.w3.org/2001/XMLSchema#string

Stephen M Prescott

http://www.w3.org/2001/XMLSchema#string

P304

1665-1670

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.ATV.0000172632.96987.2D

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Francesco Cipollone

P577

2005-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15933245

http://www.w3.org/2001/XMLSchema#string